Oscar Health, Inc.

OSCR Healthcare Healthcare Plans

Oscar Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.7 billion, up 27.5% from fiscal 2024.

Revenue
+72.1%
EPS
+201.9%
Free cash flow
−24.5%
Total debt
−37.0%

Quarter to September 2026, against a year earlier

30.65 2.53 −7.63%
Market cap
$10.2B
P/E
11.0×
Fwd P/E
15.9×
Dividend yield
—
F-score
3/9
Altman Z
1.07
Beneish M
−2.18
Dividend safety
n/a

Oscar Health, Inc. (OSCR) P/S ratio

Alert me on P/S ratio

As of 6 November 2026, Oscar Health, Inc. (OSCR) trades at a P/S ratio of 0.5×. Over the past ten years it has ranged from 0.1× (January 2023) to 3.9× (June 2021); the current reading is higher than 62% of that period. That is above the Healthcare Plans industry median of 0.4× and below the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 0.3× (8.47%)
FY2024 0.4× 2.33%
FY2023 0.3× 160.80%
FY2022 0.1× (82.74%)
FY2021 0.8× (65.27%)
FY2020 2.2× 0.00%
FY2019 2.2× —

Quarterly newest first

Period P/S ratio Change
Sep 2026 0.5× (2.97%)
Jun 2026 0.6× 118.86%
Mar 2026 0.3× (20.20%)
Dec 2025 0.3× (25.90%)
23 more quarters

Against its own ten years

Low 0.1× High 3.9×
Ten-year median 0.4×
Current reading's percentile 62

P/S ratio against peers

Company P/S ratio
CNC Centene Corporation compare 0.2×
MOH Molina Healthcare, Inc compare 0.2×
CI Cigna Group compare 0.3×
ALHC Alignment Healthcare, Inc. compare 0.3×
HUM Humana Inc. compare 0.3×
ELV Elevance Health, Inc. compare 0.5×
OSCR Oscar Health, Inc. 0.5×
CLOV Clover Health Investments, Corp. compare 0.9×
PGNY Progyny, Inc. compare 2.0×
Healthcare Plans industry median 0.4×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on OSCR